MedTrace Logo

Dual Focus Soft Contact Lens Wear Cessation Study

NCT05779072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2023-11-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the effect of ceasing treatment with dual focus soft contact lenses.

Conditions

  • Myopia

Interventions

DEVICE

Single Vision Soft Contact Lens

Subjects refit to Single Vision Soft Contact Lens for 1 year

Sponsors & Collaborators

  • Visioncare Research Ltd.

    collaborator OTHER

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Graeme Young · Visioncare Research Ltd.

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-03-01
Completion
2021-03-01
FDA Device
Yes

Countries

  • Canada
  • Portugal
  • Singapore
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05779072 on ClinicalTrials.gov